Evolent Health, Inc.
NYSE:EVH
24.96 (USD) • At close October 17, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 1,963.896 | 1,352.013 | 907.957 | 1,022.433 | 846.383 | 627.063 | 434.95 | 254.188 | 96.878 | 0 | 25.671 | 8.346 |
| Cost of Revenue
| 1,503.426 | 1,035.429 | 657.551 | 701.373 | 513.059 | 327.825 | 269.352 | 155.177 | 57.398 | 0 | 30.018 | 11.274 |
| Gross Profit
| 460.47 | 316.584 | 250.406 | 321.06 | 333.324 | 299.238 | 165.598 | 99.011 | 39.48 | 0 | -4.347 | -2.928 |
| Gross Profit Ratio
| 0.234 | 0.234 | 0.276 | 0.314 | 0.394 | 0.477 | 0.381 | 0.39 | 0.408 | 0 | -0.169 | -0.351 |
| Reseach & Development Expenses
| 26.7 | 27 | 15.5 | 15.1 | 19.8 | 18.2 | 17.2 | 11.1 | 5.8 | 0 | 2 | 0 |
| General & Administrative Expenses
| 0 | 0 | 219.499 | 310.551 | 392.82 | 306.307 | 205.67 | 160.692 | 75.286 | 0 | 15.6 | 0 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 358.11 | 269.269 | 219.499 | 310.551 | 392.82 | 306.307 | 205.67 | 160.692 | 75.286 | 0 | 15.6 | 15.977 |
| Other Expenses
| -62.525 | 67.195 | 60.037 | 61.475 | 60.913 | 0.109 | 0.171 | 0.004 | 7.166 | -25.246 | 0.001 | 0 |
| Operating Expenses
| 481.525 | 336.464 | 279.536 | 372.026 | 453.733 | 350.822 | 238.038 | 177.916 | 82.452 | -25.246 | 16.808 | 16.69 |
| Operating Income
| -71.211 | -59.835 | 30.248 | -37.882 | -120.409 | -47.48 | -72.84 | -237.419 | -42.972 | -25.246 | -21.155 | -19.619 |
| Operating Income Ratio
| -0.036 | -0.044 | 0.033 | -0.037 | -0.142 | -0.076 | -0.167 | -0.934 | -0.444 | 0 | -0.824 | -2.351 |
| Total Other Income Expenses Net
| -132.401 | -2.242 | -60.049 | -299.917 | -206.707 | -0.523 | -1.984 | -159.351 | 385.968 | -25.246 | 42.006 | 0.019 |
| Income Before Tax
| -202.405 | -62.077 | -29.801 | -337.799 | -327.116 | -54.151 | -76.404 | -237.533 | 343.289 | -25.246 | 20.031 | -19.6 |
| Income Before Tax Ratio
| -0.103 | -0.046 | -0.033 | -0.33 | -0.386 | -0.086 | -0.176 | -0.934 | 3.544 | 0 | 0.78 | -2.348 |
| Income Tax Expense
| -89.365 | -43.376 | 0.483 | -3.553 | -21.536 | 0.04 | -6.637 | -10.755 | 23.475 | 0 | 0.008 | 0.337 |
| Net Income
| -113.04 | -18.701 | -30.284 | -334.246 | -305.58 | -52.658 | -60.665 | -159.742 | 332.494 | -25.246 | 20.023 | -19.263 |
| Net Income Ratio
| -0.058 | -0.014 | -0.033 | -0.327 | -0.361 | -0.084 | -0.139 | -0.628 | 3.432 | 0 | 0.78 | -2.308 |
| EPS
| -1.02 | -0.2 | -0.35 | -3.94 | -3.71 | -0.68 | -0.94 | -3.55 | 13.14 | -0.66 | 0.063 | -1,133.12 |
| EPS Diluted
| -1.02 | -0.2 | -0.35 | -3.94 | -3.71 | -0.68 | -0.94 | -3.55 | 6.93 | -0.66 | 0.063 | -1,133.12 |
| EBITDA
| 46.381 | 7.36 | 90.285 | 23.593 | -65.466 | -8.256 | -40 | 96.833 | -449.939 | -25.246 | -66.193 | -19.505 |
| EBITDA Ratio
| 0.024 | 0.005 | 0.099 | 0.023 | -0.077 | -0.013 | -0.092 | 0.381 | -4.644 | 0 | -2.579 | -2.337 |